Tango Therapeutics TNGX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's net change in cash?
- Tango Therapeutics (TNGX) reported net change in cash of $45.12M in Q1 2026.
- How has Tango Therapeutics's net change in cash changed year-over-year?
- Tango Therapeutics's net change in cash increased by 506.6% year-over-year, from -$11.1M to $45.12M.
- What is the long-term trend for Tango Therapeutics's net change in cash?
- Over 3 years (2022 to 2025), Tango Therapeutics's net change in cash has grown at a -20.7% compound annual growth rate (CAGR), from -$85.74M to $42.75M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.